A membership giving consumers over 100 lab biomarkers a year, with a clear action plan attached, turns an annual physical's worth of labs into something a patient owns and understands themselves.
Function Health offers a membership giving consumers over 100 lab biomarkers a year with a clear action plan. Most people's relationship with lab testing is entirely reactive, a doctor orders a handful of tests only after a symptom or concern arises, and the results get filed away in a portal the patient rarely revisits or fully understands. Function's bet is that flipping that relationship, giving people a large, recurring biomarker panel proactively rather than reactively, changes how people relate to their own health data.
Ownership and interpretation, not just the raw numbers
The differentiator isn't running more tests, it's pairing a large biomarker panel with a clear, consumer-facing action plan, since raw lab results without interpretation have limited value to most people. A hundred-plus biomarker panel handed to a patient with no context would just be an intimidating spreadsheet, the interpretation layer, flagging what's out of range and explaining what to actually do about it, is what turns that raw data into something usable, and it's the part most consumer lab-testing products historically skip.
A standard annual physical typically covers a small fraction of the biomarker panel Function Health runs, reframing what "preventive testing" means for a consumer used to a much thinner default.
Prevention as a baseline, not an event
Reframing lab testing from a reactive, symptom-triggered diagnosis into a proactive, consumer-owned baseline is a genuine shift in how people relate to their own health data, not just a bigger test panel wrapped in better marketing. Once a person has a full year-over-year biomarker history of their own, health tracking stops being something that only happens when something's already wrong, and starts becoming a continuous baseline they can watch trend over time, which is a meaningfully different relationship to one's own health data than most people have ever had access to.
Whether the action-plan layer scales with membership growth
Watch whether the clinical interpretation and action-plan layer keeps pace with membership growth, since a large biomarker panel without genuinely personalized guidance risks becoming data without insight at scale. Interpretation is a much harder thing to scale than lab logistics, since it requires either a large clinical team or a very well-built decision-support system behind the scenes, and it's the piece most likely to get diluted first if membership growth outpaces the company's ability to staff or build for it.
